I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
FIALOVá, JORGA
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
43067 Risankizumab for the treatment of moderate-to-severe ..:
Kojanova, Martina
;
Fialova, Jorga
;
Cetkovska, Petra
...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB83 , 2023
Link:
https://doi.org/10.1016/..
?
2
Management of Moderate to Severe Plaque Psoriasis with Brod..:
Gkalpakiotis, Spyridon
;
Kojanová, Martina
;
Fialová, Jorga
...
Dermatology and Therapy. 14 (2023) 1 - p. 115-130 , 2023
Link:
https://doi.org/10.1007/..
?
3
Employing Adalimumab in Treatment of Moderate‐to‐Severe Hid..:
Smetanova, Alzbeta
;
Marques, Emanuel
;
Kojanova, Martina
...
Dermatologic Therapy. 2023 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1155/..
?
4
Long-Term Efficacy, Safety, and Drug Survival of Guselkumab..:
Hugo, Jan
;
Kojanova, Martina
;
Turkova, Barbora
...
Dermatology and Therapy. 13 (2023) 3 - p. 787-801 , 2023
Link:
https://doi.org/10.1007/..
?
5
Real-World Evidence From More Than 1000 Patients Treated Wi..:
The BIOREP Study Group
;
Kojanova, Martina
;
Cetkovska, Petra
...
Dermatology and Therapy. 11 (2021) 2 - p. 543-553 , 2021
Link:
https://doi.org/10.1007/..
?
6
Risankizumab for the Treatment of Moderate-to-Severe Psoria..:
Gkalpakiotis, Spyridon
;
Cetkovska, Petra
;
Arenberger, Petr
...
Dermatology and Therapy. 11 (2021) 4 - p. 1345-1355 , 2021
Link:
https://doi.org/10.1007/..
?
7
Characteristics and risk profile of psoriasis patients incl..:
Kojanova, Martina
;
Fialova, Jorga
;
Cetkovska, Petra
...
International Journal of Dermatology. 56 (2017) 4 - p. 428-434 , 2017
Link:
https://doi.org/10.1111/..
?
8
Dupilumab for the treatment of atopic dermatitis: real-worl..:
Martina Kojanova
;
Milena Tanczosova
;
Daniela Strosova
...
http://dx.doi.org/10.1080/09546634.2022.2043545. , 2022
Link:
https://doi.org/10.1080/..
?
9
Efficacy, safety, and drug survival of patients with psoria..:
Martina Kojanova
;
Jan Hugo
;
Barbora Velackova
...
http://dx.doi.org/10.1080/09546634.2022.2082354. , 2022
Link:
https://doi.org/10.1080/..
?
10
Real-world Evidence From More Than 1000 Patients Treated Wi..:
Martina Kojanova (10020822)
;
Petra Cetkovska (10020825)
;
Daniela Strosova (10020826)
...
https://figshare.com/articles/media/Real-world_Evidence_From_More_Than_1000_Patients_Treated_With_Adalimumab_for_Moderate-to-severe_Psoriasis_in_The_Czech_Republic/13626329. , 2021
Link:
https://doi.org/10.6084/..
?
11
Risankizumab for The Treatment of Moderate-to-Severe Psoria..:
Adis journals on behalf of: (10309791)
;
Spyridon Gkalpakiotis (10020831)
;
Petra Cetkovska (10020825)
...
https://figshare.com/articles/media/Risankizumab_for_The_Treatment_of_Moderate-to-Severe_Psoriasis_Real-Life_Multicenter_Experience_from_The_Czech_Republic/14610570. , 2021
Link:
https://doi.org/10.6084/..
1-11
